Cytokinetics CYTK
NASDAQ CYTK
$65.60 -0.02 (-0.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Cost of Revenue (2026)

Updated

Cytokinetics (CYTK) recorded Cost of Revenue of $2.73 million in Q2 2026.

Analysis

Cytokinetics (CYTK) Cost of Revenue (2026) Analysis & Trends

On a TTM basis, Cytokinetics' Cost of Revenue came in at $2.89 million as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Cytokinetics 9.12 Bn 5.29 Bn 25.89 Mn 2.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.73 Mn
Mar 31, 2026 160,000.00
API Access

Cytokinetics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CYTK&period=max&api_key=YOUR_API_KEY